Trials / Terminated
TerminatedNCT01810575
Efficacy & Safety of Single Dose Alprostadil Cream (2 Concentrations Enhancer) to Vehicle in Men w/Erectile Dysfunction
A Study to Assess the Relative Efficacy and Safety of a Single Dose of Alprostadil Cream Combined With 2 Concentrations of WC3036 Compared to Vehicle in Subjects With Erectile Dysfunction
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Warner Chilcott · Industry
- Sex
- Male
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the safety \& efficacy of a single dose of alprostadil cream with 2 concentrations of WC3036 compared to vehicle alone in men with erectile dysfunction.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | WC3036-11F/Alprostadil in Vehicle 2.5% | 330 mcg alprostadil in 2.5% vehicle |
| DRUG | WC3036-12F/Alprostadil in Vehicle 0.5% | 330 mcg alprostadil in 0.5% vehicle |
| DRUG | WC3036-13P/Vehicle Only 0.5% | 100 mg cream vehicle 0.5%. |
Timeline
- Start date
- 2013-02-01
- Primary completion
- 2013-04-01
- Completion
- 2013-04-01
- First posted
- 2013-03-13
- Last updated
- 2014-08-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01810575. Inclusion in this directory is not an endorsement.